NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant.

Source:http://linkedlifedata.com/resource/pubmed/id/7821711

Download in:

View as

General Info

PMID
7821711